Introduction
The 4-demethoxy derivate of daunorubicin, idarubicin is more effective than the parent compound in treating AML. [1] [2] [3] [4] The higher lipophilicity of idarubicin and its apparently reduced sensitivity to multi-drug resistance (MDR) mechanisms like the P-glycoprotein (Pgp) or the multi-drug resistance-associated protein (MRP1) have been suggested as an explanation. Supporting data are found in a study by Hargrave et al 5 who reported that idarubicin did not induce Pgp expression in the K 562 human leukemia cell line whereas other anthracyclines did. Moreover, the MDR sublines that expressed Pgp remained sensitive to idarubicin, which was confirmed by Berman et al 6 and Michieli et al. 7 In addition, Davey et al 8 demonstrated that when daunorubicin accumulation was measured by flow cytometry (FCM), it was reduced in both the MRP1 (CEM/1000) and Pgp (CEM/VBL1000) expressing cell lines, whereas idarubicin accumulation was reduced only in Pgp expressing cells. In contrast, several in vitro studies showed that in Pgp expressing cell lines cellular accumulation of idarubicin was faster and higher than that of daunorubicin, although extrusion by Pgp was comparable. 9, 10 Furthermore, Mulder et al 11 tested in a flow-through system the cytosolicfree drug concentration of several anthracyclines with increasing lipophilicity in Pgp expressing KB8-5 cells and concluded that Pgp-mediated export of the anthracyclines was similar. 6, 7 Correspondence: MEP Smeets, Division of Hematology, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands; Fax: +31-24-3542080 Received 24 November 1998; accepted 17 May 1999 The question remains how to explain the inconsistent data of idarubicin and daunorubicin sensitivity to Pgp and/or MRP1. Differences in cell size between cell lines and molar fluorescence of anthracyclines complicate comparison and interpretation of cellular content or concentration when established methods like FCM are used. Moreover, distinction between cytoplasmic and bound nuclear anthracyclines can only be made by using techniques like microspectrofluorometry or measuring DNA intercalation by their fluorescence quenching. [12] [13] [14] Anthracycline DNA intercalation is directly correlated with drug-induced cytotoxicity. 15 Belloc et al 15 demonstrated the applicability of fluorescence resonance energy transfer (FRET) by a single laser excitation to determine measured anthracycline intercalation into DNA.
To study whether idarubicin and daunorubicin cytotoxicity is affected by the presence of Pgp and/or MRP1, the FRET method was applied to determine DNA intercalation in Pgp and MRP1 expressing cell lines and normal CD34
+ hematopoietic progenitors. We compared anthracycline DNA intercalation with the simultaneous measurement of cellular drug uptake by total cellular fluorescence.
Measurement of anthracycline DNA intercalation by FRET proved to be a more sensitive and more suitable technique than measurement of total cellular fluorescence and was independent of cell size and molar anthracycline fluorescence. This method showed that daunorubicin intercalation was reduced by both Pgp and MRP1 expression. The effect of Pgp on idarubicin intercalation was very limited, but MRP1 strongly decreased idarubicin DNA intercalation.
Materials and methods

Cell lines
The adherent Pgp expressing ovarian carcinoma cell line A2780/dox5 16, 17 and the leukemia cell line HL60/ADR [18] [19] [20] displaying the MRP1 phenotype and their parent cell lines A2780/WT and HL60/WT were cultured in Iscove's medium (Life Technologies, Paisley, UK) supplemented with 10% heatinactivated fetal calf serum (FCS; Hyclone, Logan, UT, USA), 2 mM glutamine and 100 IU/ml penicillin, at 37°C in a humidified atmosphere with 5% CO 2 . The cells were used in an exponential growth phase and all cultures were routinely checked for mycoplasma contamination. Pgp and MRP1 expression on the various cell lines was confirmed by Pgp staining with the specific monoclonal antibodies MRK16 (ITK Diagnostics, Uithoorn, The Netherlands) and UIC2 (Immunotech, Marseille, France) and MRP1 staining with MRPr1 (ITK).
Chemicals
Daunorubicin (Rhone-Poulenc Rorer, Amstelveen, The Netherlands) and idarubicin (Farmitalia, Carbo Erba, Belgium)
were dissolved in phosphate-buffered saline (PBS) (NPBI, Emmer-Compascuum, The Netherlands) and stored at −20°C as a sterile stock (50 g/ml). The fluorescent dye Hoechst 33342 (H33342) was purchased from Sigma (New York, NY, USA). The modulators verapamil (Knoll, Ludwigshaven, Germany) and cyclosporin A (Novartis, Basel, Switzerland) were purchased, PSC 833 was kindly supplied by Novartis and PAK 104P by Nissan Chemical (Chiba, Japan) and dissolved in DMSO.
Flow cytometry
A multiparameter flow cytometry (FCM) method using a Coulter Epics Elite Flow cytometer (Coulter, Miami, FL, USA) with dual lasers was developed to measure anthracycline intercalation into the DNA and cellular fluorescence in the same cell. Cells were first excited with an argon laser emitting at 488 nm running at 15 mWatt (mW). After 30 s, the cells were again excited with an UV laser emitting at 351 nm running at 100 mW. Gating on forward and right angle scatter was used to exclude dead cells and debris. Data from 0.5-1 × 10 4 cells were acquired. H33342 and anthracycline fluorescence intensity was measured using a 450 band pass (BP) filter and a 575 BP filter, respectively. Intercalation of anthracyclines into the DNA results in a left shift of the diploid peak of the H33342 DNA histogram, an effect referred to as fluorescence resonance energy transfer (FRET). This shift of the DNA histogram is independent of the DNA content but correlated with the amount of anthracyclines intercalated into the DNA. 15 The relative shift (RS) of the diploid peak, which is the low intensity peak of the Hoechst histogram, represents transmission efficiency (TE) and is defined as TE = FO − Fx/F0, where F0 is the fluorescence of the diploid peak of the DNA histogram of the reference (control) and Fx the fluorescence of the diploid peak of the test sample with anthracyclines.
Accumulation assay
Samples of 0.5-1 × 10 6 cells were incubated in Iscove's medium (Life Technologies) with increasing concentrations of daunorubicin or idarubicin and 5 M H33342 (120 min, 37°C) with or without increasing concentrations of the MDR modulators verapamil, PSC 833, cyclosporin A or PAK 104P. After 120 min accumulation, a steady state is reached that reflects equilibrium between uptake and efflux mechanisms. At this time, temperature was reduced by putting the cells on ice and controlled at 4°C in a refrigerator to stop further accumulation and efflux. The difference or increased accumulation in the presence of a modulator proves the role and contribution of the efflux mechanisms. MDR modulators do not directly influence the kinetics of anthracycline uptake. H33342 and anthracycline fluorescence was measured simultaneously by FCM. The RS of the H33342 DNA histogram (or TE) was calculated.
Efflux assay
Samples of 0.5-1 × 10 6 cells were incubated in Iscove's medium with increasing concentrations of daunorubicin or idarubicin (60 min, 37°C). After centrifugation, the cells were reincubated in anthracycline-free Iscove's medium supplemented with 5 M H33342 both in the presence and absence of the MDR modulators verapamil, PSC 833, cyclosporin A or PAK 104P (120 min at 37°C). Total cellular fluorescence and H33342 fluorescence were measured by FCM. The RS of the H33342 DNA histogram (or TE) was calculated.
A rhodamine efflux assay was used to demonstrate Pgp and/or MRP1 efflux of both cell lines. The rhodamine efflux assay has proven the most sensitive method to detect functional Pgp. Rhodamine can also be extruded by MRP1. This MRP1-mediated rhodamine efflux is less pronounced and can only be detected after a prolonged efflux of at least 2 h as used in our experiments.
19 H33342 is also a substrate of Pgp efflux, 21, 22 but currently no data are available about the influence of MRP1 expression on H33342 accumulation. Therefore, H33342 efflux was studied in A270 and HL60 cells by means of the H33342 efflux assay (without exposure to anthracyclines). Cells were incubated in Iscove's medium with 5 M H33342 or 0.3 M rhodamine (60 min, 37°C). After centrifugation, cells were resuspended in H33342 or rhodaminefree Iscove's medium and incubated at 37°C for 120 min. Efflux was stopped by putting the cells on ice.
Sensitivity of measurement of DNA intercalation and cellular fluorescence
To compare the sensitivity of the measurement of anthracycline DNA intercalation and the total cellular fluorescence, the RS of the H33342 histogram and cellular fluorescence (A) were first plotted for increasing concentrations (C) and then fitted with the first order rate equation
). The first parameter A max is the final RS or maximum fluorescence in arbitrary units. The second parameter C70 is the concentration where 70% of A max is reached. The C70 represents the sensitivity of the method.
Isolation and sorting of CD34
+ cells
Normal CD34
+ hematopoietic progenitors have a physiologically low, heterogeneous but functionally relevant Pgp expression. No data are available in the literature about MRP1 expression on these cells. By means of the rhodamine efflux assay, rhodamine dull cells with a relatively high and rhodamine bright cells with a relatively low MDR expression can be distinguished. CD34 + cells were isolated from normal bone marrow with directly conjugated CD34 antibody-coupled immunomagnetic beads (M-450, coated with '561' a class III epitope anti-CD34; Dynal, Oslo, Norway). After a rhodamine efflux assay (60 min incubation with rhodamine 0.3 M, followed by 120 min efflux in dye-free Iscove's medium) a subpopulation of 20-30% of the cells appeared to be rhodamine dull. Twenty-five percent of the most rhodamine dull and 25% of the most rhodamine bright CD34 + cells were sorted using a Coulter Epics Elite FCM. Isolation, cryopreservation, thawing, rhodamine staining and sorting procedures have been described previously. 23 DNA intercalation and cellular fluorescence of anthracyclines were studied by FCM in 10 4
CD34
+ cells/sample.
Cytotoxicity assay
Daunorubicin toxicity to CD34 + cells was studied in a single cell clonogenic assay, as described previously. 23 In summary, single rhodamine dull and bright CD34 + cells were sorted in round-bottom 96-well plates prefilled with medium at increasing daunorubicin concentrations with or without 10 M verapamil. The clonogenic capacity of the cells was evaluated after 18 days. Anthracycline toxicity was expressed as the % of colonies determined Ͼ50 cells/well in the presence of anthracyclines, compared to control. The 50% inhibitory daunorubicin concentration (IC 50 ) was extrapolated from the fitted dose response curves.
Statistical analysis
A series of at least four different anthracycline concentrations was tested in each experiment and every experiment was performed at least in triplicate Student's t-test was employed for statistical analysis of the results.
Results
H33342 and rhodamine fluorescence in A2780 and HL60 cells
Since the shift of the H33342 fluorescence is used to quantify anthracycline DNA intercalation, the effects of H33342 accumulation was studied in the Pgp expressing A2780/dox5 and MRP1 expressing HL60/ADR cell lines and compared with the rhodamine accumulation ( Figure 1 ). Rhodamine retention was lower in the Pgp expressing A2780/dox5 cell line than its parent cell line after 2 h efflux. Differences in rhodamine retention between the MRP1 expressing HL60/ADR cell line and its parent cell line were less abundant than in the A2780 cell lines.
A high H33342 efflux was expected in A2780/dox5 cells. Consequently, the H33342 efflux assay resulted in a lower H33342 signal in A2780/dox5 cells compared with the A2780/WT cells. No difference in H33342 signal was measured between HL60/WT and HL60/ADR cells, suggesting that H33342 accumulation is not MRP1 dependent.
Similar results were obtained with the H33342 accumulation assay. Increased H33342 retention in the presence of a Pgp and/or MRP1 modulator is used to confirm Pgp-and/or MRP1-mediated efflux. The H33342 signal of A2780/dox5 cells was significantly (P = 0.0003) lower compared to A2780/WT cells, but increased significantly (P = 0.0007) in the presence of verapamil or PAK 104P. No difference in H33342 fluorescence was measured in HL60/ADR and HL60/WT cells and the H33342 signal was not affected by verapamil or PAK 104P, either in HL60/ADR or HL60/WT cells (Table 1 ).
These data demonstrate the difference in MDR expression of both cell lines and prove that MRP1 does not influence H33342 accumulation in contrast to Pgp, which decreases H33342 accumulation. The H33342 efflux assay might be an appropriate method to distinguish MRP1 from Pgp expression.
Measurement of anthracycline DNA intercalation simultaneously with anthracycline cellular fluorescence
Staining of living cells with H33342 showed a fluorescence distribution that reflects the DNA content. In the H33342 histogram a peak at 2 N DNA, represents G0-G1 cells, a peak at histogram correlated with a gradual increase in cellular daunorubicin fluorescence.
The relative shift (RS) of the DNA histogram, which represents transmission efficiency (TE), was calculated as described in Materials and methods. The relation between daunorubicin fluorescence and RS of the DNA histogram is shown in Figure 3 . Initially, at low daunorubicin concentrations, DNA intercalation and cellular fluorescence showed almost a linear relationship with the daunorubicin concentration. At daunorubicin concentrations more than 5 g/ml the RS leveled off, implying saturation of anthracycline intercalation into the DNA. In contrast, the cellular fluorescence showed a steady increase up to concentrations Ͼ30 g/ml.
Idarubicin and daunorubicin accumulation and modulation in Pgp expressing cells
A concentration-dependent increase in DNA intercalation and cellular fluorescence was observed when the Pgp expressing cell line A2780/dox5 and its parent cell line were exposed to daunorubicin or idarubicin (Figure 3 ). At 30 g/ml daunorubicin DNA intercalation reached a plateau in A2780/WT cells, but not in A2780/dox5 cells. As expected, daunorubicin DNA intercalation was lower in A2780/dox5 cells than in A2780/WT cells. In A2780/dox5 cells daunorubicin efflux was completely reversed in the presence of 25 M verapamil, resulting in similar DNA intercalation as seen in the A2780/WT cells (Figure 3a) . The effect of MDR modulators in A2780/dox5 cells appeared dependent on the concentration of the modulator. Daunorubicin accumulation reached maximal levels in the presence of 10 M verapamil, 4 M PSC 833, 7 M cyclosporin A or 5 M PAK 104P (Figure 4a, b, c and  d) . Idarubicin intercalation into DNA was almost similar for both the resistant and the WT A2780 cells (Figure 3c ). The addition of 25 M verapamil did not markedly influence idarubicin intercalation. Cellular fluorescence, measured simultaneously with dual lasers FCM, did not show saturation for daunorubicin either in A2780/dox5 or in A2780/WT cells (Figure 3b) . The idarubicin fluorescence curve in the range of concentrations used in this experiment tended to level off, but no plateau was observed at the concentrations used (Figure 3d) .
The difference in accumulation kinetics between daunorubicin and idarubicin was confirmed in an efflux assay. Again, idarubicin intercalation was high in both resistant and WT A2780 cell lines whereas the increase in the presence of verapamil was limited ( Figure 5 ). Increased DNA intercalation in the presence of verapamil proves the influence of the efflux mechanism. These data demonstrate that, indeed, idarubicin is a poor substrate for Pgp.
In the presence of verapamil, cellular fluorescence was different between the A2780/WT and the A2780/dox5 cell lines at high anthracycline concentrations. The variation in cellular fluorescence was not reflected in differences in intercalation into the DNA.
The maximum RS of the DNA histogram for daunorubicin and idarubicin were equal (0.8-0.9).
In all cell lines the C70 (concentration (g/ml) 70% of A max ) of both daunorubicin and idarubicin were lower for the RS compared to the C70 for cellular fluorescence. The C70 of daunorubicin in A2780/dox5 and A2780/WT was 12.5 ± 21.8 g/ml and 4.3 ± 1.1 g/ml for the RS, and 36.2 ± 50.9 g/ml and 55.3 ± 89.0 g/ml for the cellular fluorescence. The C70 of idarubicin in A2780/dox5 and A2780/WT was 3.1 ± 1.0 g/ml and 2.4 ± 0.8 g/ml for the RS and 27.7 ± 24.6 g/ml and 13.2 ± 52.6 g/ml for the cellular fluorescence respectively (Table 2) .
Idarubicin and daunorubicin accumulation and modulation in MRP1 expressing cells
The anthracycline efflux assay was used to study accumulation of idarubicin and daunorubicin in the MRP1 expressing HL60/ADR cell line and its parent, non-resistant cell line. A concentration-dependent increase in DNA intercalation and cellular fluorescence (data not shown) of both daunorubicin and idarubicin was measured in the HL60 cell lines. Intercalation was saturated at high concentrations in the WT cell line. DNA intercalation was lower in HL60/ADR cells for both daunorubicin and idarubicin than in WT and A2780/dox5 cells (Figure 6a and b) . Daunorubicin DNA intercalation was not saturated despite high daunorubicin concentrations. MRP1 could not be blocked completely at optimal Pgp blocking concentrations of the modulators PSC 833 (4 M), cyclosporin A (7 M) and verapamil (10 M). At optimal Pgp blocking concentrations only PAK 104P (5 M) also completely blocked the MRP1-mediated daunorubicin efflux (Figure 6a) .
The C70 daunorubicin in HL60/ADR and HL60/WT was 14.8 ± 3.8 g/ml and 5.7 ± 4.3 g/ml for the RS, and 14.6 ± 21.4 g/ml and 27.6 ± 28.2 g/ml for the cellular fluorescence. The C70 idarubicin in HL60/ADR and HL60/WT was 3.6 ± 0.6 g/ml and 2.5 ± 0.8 g/ml for the RS and 6.3 ± 4.5 g/ml and 7.9 ± 5.8 g/ml for the cellular fluorescence respectively (Table 2) .
DNA intercalation, cellular fluorescence and cytotoxicity of daunorubicin in CD34
In a clonogenic assay the IC 50 of daunorubicin was 0.005 g/ml and 0.0025 g/ml for the rhodamine dull and bright cells, respectively. Verapamil increased daunorubicin toxicity significantly (IC 50 : 0.0025 g/ml, P Ͻ 0.05) in the rhodamine dull fraction, even after correction for a variable but minor (Ͻ10%) intrinsic toxicity of the modulator. Verapamil did not influence daunorubicin toxicity of the rhodamine bright CD34 + cells. The daunorubicin efflux assay resulted in a concentration-dependent effect on DNA intercalation and cellular fluorescence (Figure 7a and b) . Daunorubicin DNA intercalation was lower in the rhodamine dull than in the rhodamine bright cells. Based on the cytotoxicity studies, an increase in DNA intercalation and cellular fluorescence was expected in the rhodamine dull cells. An increased daunorubicin DNA intercalation was observed only in the rhodamine dull cells and not in the rhodamine bright cells, confirming the difference in Pgp expression. In contrast to the studies with cell lines differences were less pronounced, reflecting the lower MDR expression of these cells. Cellular daunorubicin fluorescence was higher in the rhodamine bright cells than in the rhodamine dull cells. However, no increase of cellular fluorescence could be measured by verapamil. These data demonstrate that the measurement of cellular anthracycline concentration by DNA intercalation correlates better with drug-induced cytotoxicity than the measurement of total cellular fluorescence.
Discussion
Measurement of DNA intercalation was applied to study daunorubicin and idarubicin accumulation in established Pgp and MRP1 expressing cell lines and normal CD34
+ hematopoietic progenitors and compared with simultaneous cellular fluorescence measurements. Daunorubicin intercalation into the DNA was lower in the Pgp expressing (A2780/dox5) cell line compared to its parent cell line, but the difference was com- pletely abolished by MDR modulators. The MRP1 expressing (HL60/ADR) cell line also showed a lower daunorubicin DNA intercalation compared to its parent cell line. The effect of Pgp on idarubicin DNA intercalation was negligible. In contrast, MRP1 expression reduced idarubicin DNA intercalation and this effect could be blocked completely by established MRP1 modulators. We conclude that both Pgp and MRP1 reduce daunorubicin DNA intercalation, whereas idarubicin DNA intercalation is not influenced by Pgp, but only by MRP1. These differences implicate that the idarubicin efflux assay might be an additional method to detect MRP1 expression and discriminate it from Pgp expression.
Regarding the problems and confusing data in the past as a result of the heterogeneity of Pgp detection methods, it is necessary to introduce, compare and validate different MRP1 detection methods up front. H33342 is a known substrate for Pgp. 21, 22 The role of MRP1 on H33342 retention has not been determined yet. We showed by efflux and accumulation studies that H33342 is not a substrate for MRP1. Rhodamine is a better substrate for Pgp than MRP1, but the rhodamine efflux assay with a long (2 h) efflux is a sensitive method to detect both Pgp-and MRP1-mediated efflux. 19, 24, 25 Comparison of H33342 and rhodamine efflux may provide another functional assay for discriminating Pgp from MRP1. The data of our DNA intercalation studies are in agreement with previous studies by Hargrave et al, 5 Berman et al 6 and Michieli et al, 7 demonstrating that idarubicin was effective in Pgp expressing cell lines. In contrast, several other studies showed that idarubicin efflux by Pgp occurred at comparable rates as daunorubicin. [9] [10] [11] Confusing are the results of Davey et al 8 who proved that idarubicin accumulation was reduced only in Pgp expressing cells and not in MRP1 expressing cells. Ross et al 26 showed by accumulation studies with various HL60 cell lines, that idarubicin efflux was less pronounced than daunorubin, but not completely independent of MDR, in particular MRP1. Harvie et al 27 showed that induction of MRP1 expression on CEM human T cell leukemia cell lines with radiation resulted in an increased daunorubicin and idarubicin resistance. These last two studies support our conclusions that both daunorubicin and idarubicin DNA intercalation are affected by MRP1 expression.
In several previous studies analysis and comparison has been made mainly by measurement of cellular fluorescence. The fluorescence signal represents only the cellular anthracy-
Figure 5
Measurement of idarubicin intercalation into DNA by means of the idarubicin efflux assay in A2780/dox5 cells. A2780/dox5 cells were incubated with idarubicin (60 min, 37°C). After centrifugation, cells were reincubated in anthracycline-free Iscove's medium supplemented with 5 M H33342 both in the absence and presence of the MDR modulator verapamil (120 min, 37°C). H33342 fluorescence was measured by FCM. The RS of the H33342 histogram by idarubicin was calculated.
Table 2
Sensitivity cline content. This signal is influenced by differences in cell size and intracellular distribution. Comparison of different anthracyclines by FCM is even more complicated. Anthracyclines like daunorubicin and idarubicin have a different molar cytotoxicity, lipophilicity, but also molar fluorescence, making it difficult to compare equimolar concentrations. DNA intercalation studies have resolved these difficulties. Belloc et al studied intensively the mechanism of FRET between the H33342 and anthracyclines. The lipophilic bisbenzimide, H33342, a vital nuclear stain, was used as donor fluorescent molecule with a good affinity to DNA and emission spectrum overlapping the excitation spectrum of anthracyclines. The transfer efficiency appeared independent of the amount of DNA and of the amount of H33342 bound to DNA but correlated with the amount of anthracyclines. 15 Competition between H33342 and anthracyclines for DNA binding is unlikely as H33342 has a specific non-intercalative binding to adenosine thymidine pairs in the minor groove of the DNA and minimal binding to RNA, whereas anthracyclines bind in an intercalative way and form a ternary complex with topoisomerase II and DNA. 28 A relevant competition between H33342 and anthracyclines for Pgp/MRP1 in our efflux assay is not expected. Belloc et al proved that transmission efficiency (TE) was independent of the amount of bound H33342. Moreover, they showed that in a Pgp expressing cell line, a progressive increase of H33342 showed little effect on TE. We tested several H33342 concentrations to obtain a reliable H33342 signal also in the Pgp/MRP1 expressing cell lines. No differences in anthracycline DNA accumulation were observed by adding H33342 before, after or simultaneously with the anthracyclines to the cells, and both the H33342 and anthracycline accumulation were at steady state after 2 h exposure (data not shown). Since we proved that H33342 is not a substrate for MRP1, H33342 accumulation will certainly not modulate MRP1-mediated efflux of anthracyclines. Moreover, DNA intercalation has been studied by calculation of the RS of the DNA histogram, rather than the absolute H33342 fluorescence.
Intercalation into DNA is supposed to be the main site of action of anthracyclines. The formation of a cleavable complex between DNA and topoisomerase II and its stabilization by anthracyclines, which involves drug's binding to DNA is the center of their antiproliferative and cytoxic effects. Generation of free radicals causing DNA strand scission, lipid peroxidation and disruption of cell membrane functions and integrity also contribute to the antiproliferative and cytotoxic effects of classical anthracyclines. [29] [30] [31] Gieseler et al 32 showed that anthracycline DNA intercalation was directly correlated with toxicity.
In our experiments, measurement of cellular fluorescence showed a wide variation particularly at high concentrations. Optimal MDR blockade of the MDR cell lines did not always result in the expected cellular fluorescence signal comparative to the WT cell lines. Anthracycline binding to DNA was more discriminative at low anthracycline concentrations and reached saturation at lower anthracycline concentrations than cellular fluorescence. Differences in molar fluorescence between daunorubicin and idarubicin did not influence the measurement of maximal DNA intercalation, in contrast to cellular fluorescence. The optimal RS (0.8-0.9) was similar for all cell lines. In our opinion, anthracycline DNA intercalation is a more sensitive and appropriate method than cellular fluorescence and allows more precise study of the effects of drug transporters on anthracycline efficacy.
Anthracycline DNA intercalation studies were adequate in MDR cell lines, but these cell lines have a high Pgp or MRP1 expression. We also studied DNA intercalation and cellular fluorescence in normal CD34
+ hematopoietic progenitors, which have a physiologically low MDR expression compared to these cell lines. Rhodamine bright and rhodamine dull hematopoietic progenitors were sorted, with a relatively low and high MDR expression, respectively. This difference in MDR expression was functionally significant as substantiated by the results of the cytotoxicity assays. Cytotoxicity studies proved that daunorubicin toxicity increased by substitution of verapamil only in the rhodamine dull cells, hereby confirming the MDR expression of these cells. Since the curve of the dull cells in the presence of verapamil superimposed the bright cells, Pgp modulation was complete. In accordance with the differences in Pgp expression, DNA intercalation of daunorubicin was higher in rhodamine bright CD34
+ cells compared to rhodamine dull cells and only the rhodamine dull cells showed an increase of DNA intercalation in the presence of verapamil. Interpretation of differences in cellular fluorescence between rhodamine bright and dull CD34
+ cells is complicated, since rhodamine bright CD34
+ cells are two to four times larger compared to the rhodamine dull cells. The differences in cellular fluorescence can be explained by differences in cell size or fluorescence distribution and may not reflect the difference in MDR expression. An increase of cellular fluorescence was also expected in rhodamine dull cells in the presence of verapamil. However, cellular fluorescence was not modulated by verapamil either in rhodamine dull or bright CD34
+ cells. Studying only cellular fluorescence did not elucidate the differences in MDR expression between these rhodamine dull and rhodamine bright progenitor samples. These studies demonstrate that DNA intercalation measurement by FRET correlates better with survival than measurement of cellular fluorescence and is a sensitive method to detect physiological levels of MDR expression.
Several MDR modulators are capable of restoring anthracycline accumulation by blocking Pgp-and/or MRP1-mediated transport. In agreement with other in vitro studies, we showed that verapamil, cyclosporin A, PSC 833 and PAK 104P are all effective Pgp modulators. In our assay verapamil, PSC 833 and cyclosporin A at optimal Pgp blocking concentrations were less effective to modulate MRP1. The use of PAK 104P appeared preferable since complete blockade of both Pgp and MRP1 efflux at the same drug concentration was achieved. Specificity of the tested modulators is in agreement with previous reports. 25, [33] [34] [35] In conclusion, MRP1 and not Pgp expression affect idarubicin DNA intercalation. The idarubicin, but also H33342 efflux assay may provide a functional assay for discriminating Pgp from MRP1. Anthracycline DNA intercalation is more sensitive and correlates better with survival than total cellular fluorescence. The use of PAK 104P may be preferable over PSC833, verapamil and cyclosporin A to overcome both Pgpand MRP1-related drug resistance.
